Press Releases

 Filter by Provider

The "Poland Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering.

Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced it has agreed to sell Stellant Systems, Inc (“Stellant” or “the Company”), a premier designer and manufacturer of radio frequency (“RF”) and microwave amplification products, to TransDigm Group Incorporated ("TransDigm Group") (NYSE: TDG), a leading global designer, producer and supplier of highly engineered aircraft components, for $960 million.

DALLAS, TX / ACCESS Newswire / December 31, 2025 / Black Dragon Resource Companies, Inc. (OTCID:BDGR), ("The Company") a partly held company of Auri Inc, ("OTCID:AURI") and its new management announces end of year Letter to Wish Stakeholders a Happy New Year!

Transaction in Own Shares   

Total Voting Rights 

Giving glove materials a verifiable "memory" to support safe recovery, traceability, and circular reuse

SAN DIEGO, CA / ACCESS Newswire / December 31, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced the Company received written notification from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq"), granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5810(c)(3)(A) (the "Bid Price Rule"). The Company now has until June 29, 2026 to meet the requirement. If at any time prior to June 29, 2026, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Bid Price Rule.

New orders strengthen Ondas' record 2025 trajectory across counter-UAS, UAS, UGVs, and other mission-critical security capabilities

DALLAS, TX / ACCESS Newswire / December 31, 2025 / Auri Inc. (OTCID:AURI), a cutting-edge driven incubating holding company, releases end of year report with excitement for the Productive New Year 2026.

Board strengthened with seasoned operator to support governance, execution cadence, and capital strategy initiatives

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark" or the "Company"),...

Stockholder approval enables closing of the Sonim asset sale in January 2026NEXA to continue selling rugged phones and mobile hotspots...

Digimarc Corporation (Nasdaq: DMRC), a pioneer and global leader in digital identity and authentication solutions, will attend the 28th Annual Needham Growth Conference in New York on Tuesday, January 13, 2026. Digimarc President and CEO Riley McCormack and CFO Charles Beck will host meetings at the event, which is being held at the Lotte New York Palace Hotel.

SAN CLEMENTE, Calif., Dec. 31, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the 44th Annual J.P. Morgan Healthcare Conference being held in San Francisco, California, January 12-15, 2026. ICU Medical’s presentation will be on Wednesday, January 14, 2026 at 1:30 p.m. PT (4:30 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, January 14, 2026.

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the filing of a Phase 1/2 Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) seeking regulatory clearance to initiate clinical trials of CYPS317, an investigational allogeneic fibroblast spheroid-based therapy for the treatment of moderate to severe psoriasis.

SARASOTA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, today announced plans to distribute a new digital token to its shareholders in partnership with Crypto.com. The distribution is expected to leverage Crypto.com’s cutting-edge technology, including the high performance, interoperable Cronos blockchain designed for speed, scalability, and seamless connectivity between networks.

FAIRFIELD, Conn., Dec. 31, 2025 (GLOBE NEWSWIRE) -- HMG Strategy, the world’s leading digital platform for CIO and CISO leadership, is proud to announce its highly anticipated 2026 Global C-Level Technology Leadership Summit schedule. C-suite technology executives seeking fresh insight into how technology drives growth, reinvents the enterprise, and elevates leadership impact are invited to explore the upcoming season of premier technology events.

London, United Kingdom - In financial markets, success is often measured by returns, models, and judgment; but according to David

The "Vietnam Alternative Lending Market Size & Forecast by Value and Volume Across 100+ KPIs by Type of Lending, End-User Segments, Loan Purpose, Finance Models, Distribution Channels, and Payment Instruments - Databook Q4 2025 Update" report has been added to ResearchAndMarkets.com's offering.

HOUSTON, Dec. 31, 2025 (GLOBE NEWSWIRE) -- HyOrc Corporation (OTCID: HYOR), a clean-energy technology company, today announced the successful completion of the Factory Acceptance Test (FAT) for its 500kW Organic Rankine Cycle (ORC) turbine, which is now being prepared for shipment to Camsan Ordu, a customer project in Turkey.

The global Drone-as-a-Service (DaaS) market is booming, valued at $9.42 billion in 2022 and projected to grow at a 36.6% CAGR through 2034. Businesses in solar energy, agriculture, telecom, construction, and defense are adopting drones for surveying, inspection, monitoring, and maintenance, recognizing drones deliver data faster, safer, and more cost-effectively than traditional methods. In solar alone, drone-enabled surveying and mapping is projected to reach $1.14 billion by 2027.

The "Thailand Construction Equipment Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The "U.S. Continuing Medical Education (CME) Market Research Report 2025-2030" report has been added to ResearchAndMarkets.com's offering.

The "Home Healthcare Market Research Report 2025-2030" has been added to ResearchAndMarkets.com's offering.

The Aster Guardians Global Nursing Award 2026, an initiative from Aster DM Healthcare – a leading integrated healthcare provider, has announced the extension of its deadline to January 11, 2026. The awards have already received over 134,000 registrations from 214 countries, highlighting its growing global reach and recognition among nurses worldwide. Nurses from around the world can submit their nominations through the dedicated platform at www.asterguardians.com.

Motus, the leader in vehicle reimbursement, risk mitigation and productivity solutions for companies whose employees drive their own vehicles for work, is closing out 2025 with momentum across product innovation, strategic expansion and industry recognition. Over the past year, Motus strengthened its leadership in the business of driving, helping organizations better manage the costs, risk, and operational realities of employees who drive for work. The company also ends the year with $2.1 billion in approved reimbursements.

Spirals & Heartspace offers trauma therapy, somatic therapy, and grief counseling to support healing and resilience in Layton, Utah.

Local Repairs Now launches nationwide, providing homeowners with around-the-clock access to trusted home services professionals across the United States through a streamlined online platform.

VANCOUVER, BC, December 31 st . 2025 / - TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (OTCQB: BVAXF) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of operating initiatives over the past year following the integration of the DPX™ platform into the BioVaxys business.

Vancouver, British Columbia--(Newsfile Corp. - December 31, 2025) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) (the "Company"...

Western Asset Inflation-Linked Opportunities & Income Fund [NYSE: WIW]

LMP Capital and Income Fund Inc. [NYSE: SCD]

The 19(a) monthly distribution notices for Putnam Managed Municipal Income Trust (NYSE: PMM) and Putnam Municipal Opportunities Trust (NYSE: PMO) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement.

The 19(a) monthly distribution notices for Putnam Master Intermediate Income Trust (NYSE: PIM) and Putnam Premier Income Trust (NYSE: PPT) are now available. These informational notices provide further details on the sources of the funds’ monthly distributions and follow the most recent distribution announcement.

Western Asset Inflation-Linked Income Fund [NYSE: WIA]

Western Asset Emerging Markets Debt Fund Inc. [NYSE: EMD]

Perfect Corp. (NYSE: PERF), the leading artificial intelligence (AI) and augmented reality (AR) beauty and fashion tech solutions provider, announced the launch of an interactive suite of 2026 New Year content across the YouCam app series, including YouCam Makeup, YouCam Perfect, YouCam AI Pro, YouCam Enhance and YouCam Video. With over 1.1 billion total downloads, the YouCam apps are transforming how users celebrate the holidays, offering new ways to visualize their New Year’s resolutions and create viral-ready social content using the latest Generative AI.

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the U.S. Food and Drug Administration (FDA or the Agency) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for relacorilant as a treatment for patients with hypertension secondary to hypercortisolism.

BrandywineGLOBAL - Global Income Opportunities Fund Inc. [NYSE: BWG]

Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of results from subgroup analyses of the phase 3 FOCUS study. The publication, titled “Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma” was published in the Journal of Cancer Research and Clinical Oncology. The analysis assessed efficacy and safety in subgroups of patients treated with Delcath’s HEPZATO KIT, a drug/device combination for liver-directed treatment of mUM patients. The HEPZATO KIT is currently the only liver-directed treatment to be approved by the FDA for patients with unresectable mUM. The article provides clinically relevant subgroup analyses of key efficacy endpoints, including overall response rate (ORR), progression-free survival (PFS) and overall survival (OS), and safety categories. Prespecified subgroups included age (<65 or ≥65 years), sex (male or female) geographic region (ex-US or US) extent of tumor liver involvement (1-25% or 26-50%), hepatic tumor burden (above or below median), presence of extrahepatic lesions (yes or no), baseline LDH (low/normal or elevated) and number of prior therapies (0 or 1+).

Thiel Capital, the private investment firm founded by technology investor and entrepreneur Peter Thiel, has opened an office in Miami, Florida.

Creative Media & Community Trust Corporation (NASDAQ: CMCT) (the “Company”) announced today that its Board of Directors has declared preferred stock dividends on its Series A, Series A1 and Series D Preferred Stock for the fourth quarter of 2025. The dividend will be payable on January 15, 2026 to holders of record on January 5, 2026.

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the 44th Annual J.P Morgan Healthcare Conference on January 14, 2026 at 9:45 a.m. PT.

America250, the official nonpartisan organization established by Congress to lead the nation’s 250th anniversary commemoration, today launched its latest tentpole program, America Gives, a nationwide initiative designed to make 2026 the largest year of volunteerism in U.S. history.

VANCOUVER, British Columbia, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (“Hydreight” or the “Company”), a digital health platform enabling on-demand care, pharmacy fulfillment, and enterprise healthcare services across the United States, today announced its entry into the rapidly expanding at-home sexually transmitted infection (“STI”) pre-screening market through an exclusive distribution agreement with Health Screen Collective (“HSC”).

TARPON SPRINGS, Fla., December 31, 2025 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today issued the following letter to shareholders from the Company’s Chief Executive Officer.Dear Shareholders,

The "Spondyloarthritis (Spondyloarthropathy) - Global Clinical Trials Review, 2025" clinical trials report has been added to ResearchAndMarkets.com's offering.

New York, NY, Dec. 31, 2025 (GLOBE NEWSWIRE) -- Westin Acquisition Corp (NASDAQ): WSTNU, the “Company”), a Cayman Islands exempted company, announced that holders of its 5,750,000 units sold in the Company’s initial public offering may elect to separately trade the ordinary shares and rights included in the units, commencing on or about December 31, 2025.

New York, New York--(Newsfile Corp. - December 31, 2025) - NANO Nuclear Energy Inc. (NASDAQ: NNE) ("NANO Nuclear" or "the...

The "Lupus Nephritis - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.